Show simple item record

2018-08-09Zeitschriftenartikel DOI: 10.25646/6024
Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012
dc.contributor.authorWalter, Jan
dc.contributor.authorHaller, Sebastian
dc.contributor.authorQuinten, Chantal
dc.contributor.authorKärki, Tommi
dc.contributor.authorZacher, Benedikt
dc.contributor.authorEckmanns, Tim
dc.contributor.authorAbu Sin, Muna
dc.contributor.authorPlachouras, Diamantis
dc.contributor.authorKinross, Pete
dc.contributor.authorSuetens, Carl
dc.date.accessioned2019-03-28T10:23:10Z
dc.date.available2019-03-28T10:23:10Z
dc.date.issued2018-08-09none
dc.identifier.other10.2807/1560-7917.ES.2018.23.32.1700843
dc.identifier.urihttp://edoc.rki.de/176904/6059
dc.description.abstractAn aim of the ECDC point prevalence survey (PPS) in European Union/European Economic Area acute care hospitals was to acquire standardised healthcare-associated infections (HAI) data. We analysed one of the most common HAIs in the ECDC PPS, healthcare-associated pneumonia (HAP). Standardised HAI case definitions were provided and countries were advised to recruit nationally representative subsets of hospitals. We calculated 95% confidence intervals (CIs) around prevalence estimates and adjusted for clustering at hospital level. Of 231,459 patients in the survey, 2,902 (1.3%; 95% CI: 1.2–1.3) fulfilled the case definition for a HAP. HAPs were most frequent in intensive care units (8.1%; 95% CI: 7.4–8.9) and among patients intubated on the day of the survey (15%; 95% CI: 14–17; n = 737 with HAP). The most frequently reported microorganism was Pseudomonas aeruginosa (17% of 1,403 isolates), followed by Staphylococcus aureus (12%) and Klebsiella spp. (12%). Antimicrobial resistance was common among isolated microorganisms. The most frequently prescribed antimicrobial group was penicillins, including combinations with beta-lactamase inhibitors. HAPs occur regularly among intubated and non-intubated patients, with marked differences between medical specialities. HAPs remain a priority for preventive interventions, including surveillance. Our data provide a reference for future prevalence of HAPs at various settings.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.rights(CC BY 3.0 DE) Namensnennung 3.0 Deutschlandger
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/de/
dc.subjectinfection prevention and controleng
dc.subjectpneumoniaeng
dc.subjectpoint prevalence surveyeng
dc.subjectsurveillanceeng
dc.subjectEuropeeng
dc.subjectantibiotic useeng
dc.subjectantimicrobial resistanceeng
dc.subjectepidemiologyeng
dc.subjecthealthcare-associated infectionseng
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleHealthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012none
dc.typearticle
dc.identifier.urnurn:nbn:de:kobv:0257-176904/6059-2
dc.identifier.doihttp://dx.doi.org/10.25646/6024
dc.type.versionpublishedVersionnone
local.edoc.container-titleEurosurveillancenone
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2018.23.32.1700843#html_fulltextnone
local.edoc.container-publisher-nameInstitut de Veille Sanitairenone
local.edoc.container-volume23none
local.edoc.container-issue32none
local.edoc.container-reportyear2018none
local.edoc.container-year2018none
local.edoc.container-firstpage1none
local.edoc.container-lastpage12none
local.edoc.rki-departmentInfektionsepidemiologienone
dc.description.versionPeer Reviewednone

Show simple item record